Oncopeptides AB will release its Year-end Report on 22 February at 8:00 am CET.
The company’s CEO Jakob Lindberg will summarize the financial year 2018 and address questions from investors, analysts and media at 14:00 CET, 22 February.
An audiocast to the presentation will be available at:
Time for webcast – 14.00 (CET) on 22 February Dial in number from Sweden: +46856642706
Dial in number from UK: +443333009270
Dial in number US: +18335268382
For more information, please contact:
Rein Piir, Head of Investor Relations at Oncopeptides
Cell phone: +46 70 853 72 92